Malani_Christensen Posted - 1 hour ago

$EXAS It's time to reconsider my holdings (2864 shares) and move to other stocks.

Joe_Kennedy Posted - 1 hour ago

$EXAS will be $40 per share in 1 or 2 months. Bad news for us. Competitors are taking over the market. Sell at market open.

Felix550 Posted - 1 hour ago

Saw TMO step into the CRC sector. $EXAS and $GH are going to crash soon with such competition. We're going to see $20 per share soon. I'm out now with a bit loss.

Allie_Vo Posted - 1 hour ago

@rustycat The most important is Advanced Adenoma before people step into the cancer patient category. MYNZ has an 88% detection rate, while all others are only approved once you already HAVE IT, which you would know anyway. So all this sensitivity that you mentioned for those who already have it. But none of EXAS or GH can confirm advanced adenoma in the pre-cancer stage. This is important!!! $MYNZ $EXAS $GH

stewpackard Posted - 16 hours ago

$EXAS $75 stock

Allie_Vo Posted - 19 hours ago

$MYNZ check this out, comparison on CRC tests in US (who’s the leader???): Mainz Biomed costs $200 (88% detection) $GH Guardant Health costs $1,495 (20% detection) $EXAS Exact Sciences costs $500 (42% detection) Colonoscopy: $2,750 The average cost of a colonoscopy is $2,750, but the total can range from $1,250 to $4,800, depending on where you live, where you have the procedure performed and what your insurance covers (if you have insurance) $TMO partnership gonna change everything.

Woodman7 Posted - 1 day ago

$EXAS - Just to point out the absurdity of the recent drop in stock price: Just before the earnings release, EXAS was at approximately $72/share. After, it fell and hit a recent low of just over $48/share - losing almost exactly 1/3 (33%) of its value or approximately $4.3b in market cap. The FY outlook change was a drop of $70m in revenue ($2.83b to $$2.74b) - a 2.5% decrease. And EBITA outlook dropped $30m ($345m to $315m) - an 8.7% drop. Nothing else about the multi year story line changed! And a big chunk of the outlook change was due to delayed revenue caused by 18% of their customer base being impacted by 2 very significant hurricanes. WS reacted like the wheels had fallen off the wagon. Ridiculous! But a great buying opportunity for us. Even though it jumped up very nicely yesterday, continue to buy this dip if you can. It still has a long way to go to simply recover the oversold reaction to 3Q.

crtlabz Posted - 1 day ago

$EXAS added 278s @ $49.45

Woodman7 Posted - 1 day ago

$EXAS - per CNN article: Trump said in a statement on Tuesday. “Dr. Oz will be a leader in incentivizing Disease Prevention, so we get the best results in the World for every dollar we spend on Healthcare in our Great Country.” Key weird:PREVENTION! $EXAS

sandseven77 Posted - 1 day ago

$EXAS https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exas/exact-sciences/news/chairman-of-the-board-ceo-of-exact-sciences-picks-up-27-more?utm_medium=article&utm_source=robinhood

CDNroadwarrior Posted - 1 day ago

$EXAS Nice bounce today, not sure if there was any news that spurred the buying or if just oversold buying. Either way a nice day for the stock.

Anecdotal Posted - 1 day ago

@bearcreekzeke Kudos Zeke. Great points. $EXAS

Anecdotal Posted - 1 day ago

@investorjustin @Aaronpell $EXAS You simply can't follow any stock "minute-to-minute" any more. Instant news tends to give investors a myopic understanding of broader theses. Today is one of those days. Insiders sell for a million different reasons. The buy for only one reason.

sandseven77 Posted - 1 day ago

$EXAS still a good time to make big profits.

sandseven77 Posted - 1 day ago

$EXAS keep adding your loads. Big Profits.

sandseven77 Posted - 1 day ago

$EXAS keep buying and hold. will go above $70 by the end of the year.

sandseven77 Posted - 2 days ago

$EXAS price increasing, any news?

ManyThanks212 Posted - 2 days ago

$EXAS

StockHunter75 Posted - 2 days ago

$EXAS think I'll take a starter position here.

Woodman7 Posted - 4 days ago

$EXAS - please read this. This is the kind of nonsense that needs to be exposed and corrected. The all-in to Medicare costs of using other screening methods vs Cologuard are significantly higher and less healthful. What a waste of money… #fda

Woodman7 Posted - 4 days ago

@knowthyself - agree. I think WS is holding back waiting for clarity on the pricing decision. Hopefully it is approved and the stock takes off. $EXAS

Woodman7 Posted - 5 days ago

$PGY - would be a great time for a a big insider but like the CEO of $EXAS did this week

ThomasScher875 Posted - 5 days ago

$EXAS As an investor, it's challenging to see other companies release advanced technology while KSCP refines its existing products.

Woodman7 Posted - 5 days ago

@Sasquamch - that and I believe he will go all out on cancer prevention/screening . Going very long on $EXAS $TDOC

bearcreekzeke Posted - 5 days ago

$EXAS Given CMS' decision to pay $920 for the inferior Shield blood test, Exact Sciences really needs to aggressively pursue higher pricing for Cologuard Plus. A 25% price increase to $690 for Cologuard Plus, a vastly superior product to Shield and significantly better than original Cologuard, is clearly not enough. Especially taking into consideration the fact that for ten years, since its introduction, the Company has never requested a price increase for Cologuard. There is no way CMS should be paying Exact Sciences less for a vastly superior 3-year test than what it pays Guardant for a markedly inferior one-year test. This is crazy!!!! https://www.reddit.com/r/exactsciences/comments/1frl444/medicare_advisory_panel_narrowly_recommends/

Woodman7 Posted - 5 days ago

$EXAS - I would think that Kennedy would go all in on cancer screening/prevention. $EXAS sitting in the sweet spot.

Jasooon Posted - 6 days ago

$EXAS strong bull signal. CEO buying at these levels.

rangerhawkeye Posted - 6 days ago

$EXAS decent insider buy

knowthyself Posted - 6 days ago

$EXAS it wants to take off

STOCKPICKERTRADER Posted - 6 days ago

$EXAS started position to bottom fish and glad to see large insider purchases in here at these levels.